Amgen, US0311621009

Amgen stock: Argus lifts target to 515 US dollars

Published on 11/19/2026 at 15:47 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Amgen stock draws a fresh analyst view as Argus keeps its Buy rating. The note points to pipeline prospects, product growth and future revenue sources.

Analyst view and pipeline outlook

  • Argus kept its Buy rating while lifting its target for Amgen.
  • The analyst pointed to pipeline prospects, product volume growth and future revenue from launches, biosimilars and business development.
  • The stock was last quoted at 402.10 euros on Lang & Schwarz on Thursday afternoon.
Amgen, US0311621009, Illustration mit AI erstellt.

Argus raised its price target for Amgen to 515 US dollars from 460 US dollars on Thursday, November 12, 2026, while keeping a Buy rating on the biotech company. Markets Insider, citing TipRanks, said the analyst highlighted Amgen's pipeline and robust volume growth in its existing portfolio.

Argus sees pipeline support

The analyst expects future revenue to benefit from newly launched medicines, biosimilars and products acquired through mergers, acquisitions and in-licensing. The assessment adds a named analyst view to the recent discussion around Amgen's growth portfolio.

Trading context for investors

Amgen stock was last quoted at 402.10 euros on Lang & Schwarz at 15:36 CET on Thursday, November 19, 2026. The quote provides the latest trading context alongside the analyst action, while the target remains denominated in US dollars.

Amgen company details

  • Company: Amgen Inc.
  • ISIN: US0311621009
  • Ticker: AMGN
  • Analyst action: Argus raised the target to 515 US dollars from 460 US dollars and kept a Buy rating on November 12, 2026
  • Lang & Schwarz quote: 402.10 euros at 15:36 CET on November 19, 2026

US equities remain the broader market setting for the company. Current market reports provide the wider trading context.

More news and analyses on Amgen stock

Disclaimer...
en | US0311621009 | AMGEN | boerse | 70536698 | bgmi